596 related articles for article (PubMed ID: 18331441)
1. Angiotensin II receptor blocker inhibits tumour necrosis factor-alpha-induced cell damage in human renal proximal tubular epithelial cells.
Kagawa T; Takao T; Horino T; Matsumoto R; Inoue K; Morita T; Hashimoto K
Nephrology (Carlton); 2008 Jun; 13(4):309-15. PubMed ID: 18331441
[TBL] [Abstract][Full Text] [Related]
2. Effects of angiotensin II type 1 receptor blocker on albumin-induced cell damage in human renal proximal tubular epithelial cells.
Takao T; Horino T; Kagawa T; Matsumoto R; Inoue K; Taguchi T; Morita T; Iwasaki Y; Hashimoto K; Terada Y
Am J Nephrol; 2009; 29(2):102-8. PubMed ID: 18689996
[TBL] [Abstract][Full Text] [Related]
3. Possible roles of tumor necrosis factor-α and angiotensin II type 1 receptor on high glucose-induced damage in renal proximal tubular cells.
Takao T; Horino T; Matsumoto R; Shimamura Y; Ogata K; Inoue K; Taniguchi Y; Taguchi T; Terada Y
Ren Fail; 2015 Feb; 37(1):160-4. PubMed ID: 25222109
[TBL] [Abstract][Full Text] [Related]
4. Effects of AT1 and AT2 receptor blockade on angiotensin II induced apoptosis of human renal proximal tubular epithelial cells.
Weidekamm C; Hauser P; Hansmann C; Schwarz C; Klingler H; Mayer G; Oberbauer R
Wien Klin Wochenschr; 2002 Aug; 114(15-16):725-9. PubMed ID: 12602118
[TBL] [Abstract][Full Text] [Related]
5. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
[TBL] [Abstract][Full Text] [Related]
6. [The effect of angiotensin II on phosphoinositide-3 kinase/Akt cascade in cultured fibroblasts derived from patients with hypertrophic scars].
Liu HW; Cheng B; Wu HJ; Gu YF; Chen X; Chen ZG; Liu WZ
Zhonghua Zheng Xing Wai Ke Za Zhi; 2010 Jan; 26(1):57-60. PubMed ID: 20432929
[TBL] [Abstract][Full Text] [Related]
7. Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice.
Iwai M; Chen R; Li Z; Shiuchi T; Suzuki J; Ide A; Tsuda M; Okumura M; Min LJ; Mogi M; Horiuchi M
Circulation; 2005 Sep; 112(11):1636-43. PubMed ID: 16145000
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase C-mediated inhibition of renal Ca2+ ATPase by physiological concentrations of angiotensin II is reversed by AT1- and AT2-receptor antagonists.
Assunção-Miranda I; Guilherme AL; Reis-Silva C; Costa-Sarmento G; Oliveira MM; Vieyra A
Regul Pept; 2005 Apr; 127(1-3):151-7. PubMed ID: 15680481
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of regucalcin suppresses apoptotic cell death in cloned normal rat kidney proximal tubular epithelial NRK52E cells: change in apoptosis-related gene expression.
Nakagawa T; Yamaguchi M
J Cell Biochem; 2005 Dec; 96(6):1274-85. PubMed ID: 16167335
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of regucalcin suppresses cell response for tumor necrosis factor-alpha or transforming growth factor-beta1 in cloned normal rat kidney proximal tubular epithelial NRK52E cells.
Nakagawa T; Yamaguchi M
J Cell Biochem; 2007 Apr; 100(5):1178-90. PubMed ID: 17063480
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II infusion decreases plasma adiponectin level via its type 1 receptor in rats: an implication for hypertension-related insulin resistance.
Ran J; Hirano T; Fukui T; Saito K; Kageyama H; Okada K; Adachi M
Metabolism; 2006 Apr; 55(4):478-88. PubMed ID: 16546478
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II receptor blocker improves tumor necrosis factor-α-induced cytotoxicity via antioxidative effect in human glomerular endothelial cells.
Izawa-Ishizawa Y; Ishizawa K; Sakurada T; Imanishi M; Miyamoto L; Fujii S; Taira H; Kihira Y; Ikeda Y; Hamano S; Tomita S; Tsuchiya K; Tamaki T
Pharmacology; 2012; 90(5-6):324-31. PubMed ID: 23052181
[TBL] [Abstract][Full Text] [Related]
13. Improvement of stunned myocardium in dogs with olmesartan, an angiotensin II type 1 receptor antagonist, is independent of type 2 receptors.
Kano S; Satoh K; Kaneta S; Ichihara K
Pharmacology; 2008; 82(1):22-9. PubMed ID: 18434761
[TBL] [Abstract][Full Text] [Related]
14. Selective antagonism of the AT1 receptor inhibits the effect of angiotensin II on DNA and protein synthesis of rat proximal tubular cells.
Weerackody RP; Chatterjee PK; Mistry SK; McLaren J; Hawksworth GM; McLay JS
Exp Nephrol; 1997; 5(3):253-62. PubMed ID: 9208286
[TBL] [Abstract][Full Text] [Related]
15. Possible involvement of intracellular angiotensin II receptor in high-glucose-induced damage in renal proximal tubular cells.
Takao T; Horino T; Kagawa T; Matsumoto R; Shimamura Y; Ogata K; Inoue K; Taniguchi Y; Taguchi T; Morita T; Terada Y
J Nephrol; 2011; 24(2):218-24. PubMed ID: 20890878
[TBL] [Abstract][Full Text] [Related]
16. Tubular expression of angiotensin II receptors and their regulation in IgA nephropathy.
Chan LY; Leung JC; Tang SC; Choy CB; Lai KN
J Am Soc Nephrol; 2005 Aug; 16(8):2306-17. PubMed ID: 15930094
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin AT1 receptor activation mediates high glucose-induced epithelial-mesenchymal transition in renal proximal tubular cells.
Zhou L; Xue H; Yuan P; Ni J; Yu C; Huang Y; Lu LM
Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):e152-7. PubMed ID: 20590668
[TBL] [Abstract][Full Text] [Related]
18. Coexpression of AT1 and AT2 receptors by human fibroblasts is associated with resistance to angiotensin II.
Galindo M; Santiago B; Palao G; Gutierrez-Cañas I; Ramirez JC; Pablos JL
Peptides; 2005 Sep; 26(9):1647-53. PubMed ID: 16112405
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide contributes to AT2 but not AT1 angiotensin II receptor-mediated vasodilatation of porcine pial arteries and arterioles.
Baranov D; Armstead WM
Eur J Pharmacol; 2005 Nov; 525(1-3):112-6. PubMed ID: 16256981
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II AT2 receptors inhibit proximal tubular Na+-K+-ATPase activity via a NO/cGMP-dependent pathway.
Hakam AC; Hussain T
Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1430-6. PubMed ID: 16380464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
